Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial
Titel:
Brentuximab vedotin plus nivolumab as first-line therapy in older or chemotherapy-ineligible patients with Hodgkin lymphoma (ACCRU): a multicentre, single-arm, phase 2 trial
Auteur:
Cheson, Bruce D Bartlett, Nancy L LaPlant, Betsy Lee, Hun J Advani, Ranjana J Christian, Beth Diefenbach, Catherine S Feldman, Tatyana A Ansell, Stephen M